Atterocor is a drug development company focused on the accelerated development of a novel treatment for adrenal cancer,
a rare endocrine cancer.

Learn More

March 3, 2015
Atterocor Announces Data Presentations at ENDO 2015

December 11, 2014
Atterocor Expands Phase 1 Trial of ATR-101 to Additional Leading Adrenal Cancer Centers Read More >>